R
Rapport Therapeutics, Inc. Common Stock
RAPP · NASDAQ · Healthcare · 2.3B
Closing price
$30.65
+2.68% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
3.0×
Enterprise value / EBITDAEV/EBITDA
-11.3×
Free cash flow yieldFCF yield
-6.1%
Return on equityROE
-23.0%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.